An MUSC Medical Scientist Training Program (M.D./Ph.D.) student has been selected to be part of the 2019 Gates Cambridge Scholars Program at the University of Cambridge in Cambridge, England. Currently finishing his second year of medical school, Stephen Gadomski will begin his Ph.D. work this summer in a partnership between the National Institutes of Health and the University of Cambridge, with the four years split between the institutions.
According to the Gates Cambridge program, hirty-four of the most academically outstanding and socially committed U.S. citizens selected to be part of the 2019 class of Gates Cambridge Scholars at the University of Cambridge.”
Reacting to the news, Gadomski said, “My time at MUSC has given me a new perspective – to build a skill set with the goal of serving others. I hope to strengthen this perspective during my Ph.D. years with the diverse and like-minded Gates community.”
Gadomski’s Ph.D. work will focus on characterizing a pure skeletal stem cell population and its interaction with neighboring cell populations in the bone marrow in hopes of improving stem cell therapies for skeletal disease. He will work in a collaboration with Pamela Robey, Ph.D., senior investigator, Skeletal Biology Section, at the NIH and Simon Mendez-Ferrer, Ph.D., and Andrew McCaskie, head of the Department of Surgery, at Cambridge.
He will return to MUSC to complete his third- and fourth-year medical degree coursework. At the end of his studies, he is expected to earn an M.D. from MUSC and a Ph.D. from the University of Cambridge.
Throughout his time at MUSC, Gadomski has been collaborating with Jonathan Keller, Ph.D., senior investigator, Head, Hematopoiesis and Stem Cell Biology Section of the NIH. Together, they plan to publish their work on the bone marrow microenvironment in the coming months.
He also pursued research between his first and second years in medical school with Robey, working with a medical student from Case Western, and was involved with single cell sequencing of bone marrow stromal populations and optimizing a surgical model to test cartilage regeneration in mice.
Gadomski also worked in the lab of Stephen Duncan, Ph.D., chairman of the MUSC Department of Regenerative Medicine and Cell Biology, prior to entering medical school, working most closely with post-doctoral fellow Ray Liu, Ph.D., pursuing a line of inquiry into finding new drug therapies that lower low-density lipoprotein cholesterol using iPSC-derived hepatocyte-like cells as a model.